nodes	percent_of_prediction	percent_of_DWPC	metapath
Desipramine—CYP2D6—breast cancer	0.074	0.389	CbGaD
Desipramine—Dimetacrine—Tamoxifen—breast cancer	0.0685	0.571	CrCrCtD
Desipramine—CYP3A4—breast cancer	0.0635	0.334	CbGaD
Desipramine—SLC22A3—Melphalan—breast cancer	0.0596	0.144	CbGbCtD
Desipramine—ABCB1—breast cancer	0.0529	0.278	CbGaD
Desipramine—Promazine—Tamoxifen—breast cancer	0.0514	0.429	CrCrCtD
Desipramine—CYP2A6—Letrozole—breast cancer	0.0417	0.1	CbGbCtD
Desipramine—SLC22A3—Irinotecan—breast cancer	0.0202	0.0486	CbGbCtD
Desipramine—CYP2B6—Thiotepa—breast cancer	0.0183	0.0442	CbGbCtD
Desipramine—CYP1A2—Anastrozole—breast cancer	0.0142	0.0342	CbGbCtD
Desipramine—CYP1A2—Toremifene—breast cancer	0.013	0.0312	CbGbCtD
Desipramine—CYP2A6—Tamoxifen—breast cancer	0.0124	0.0299	CbGbCtD
Desipramine—CYP2B6—Raloxifene—breast cancer	0.0122	0.0295	CbGbCtD
Desipramine—ABCB1—Toremifene—breast cancer	0.0113	0.0273	CbGbCtD
Desipramine—SLC22A2—Vinblastine—breast cancer	0.0106	0.0256	CbGbCtD
Desipramine—CYP2C19—Lapatinib—breast cancer	0.0102	0.0247	CbGbCtD
Desipramine—CYP3A4—Exemestane—breast cancer	0.0098	0.0236	CbGbCtD
Desipramine—CYP2A6—Fluorouracil—breast cancer	0.00914	0.022	CbGbCtD
Desipramine—CYP2D6—Idarubicin—breast cancer	0.00885	0.0213	CbGbCtD
Desipramine—CYP3A4—Letrozole—breast cancer	0.00833	0.0201	CbGbCtD
Desipramine—ABCB1—Lapatinib—breast cancer	0.00827	0.0199	CbGbCtD
Desipramine—CYP2E1—Tamoxifen—breast cancer	0.00819	0.0197	CbGbCtD
Desipramine—CYP2B6—Tamoxifen—breast cancer	0.00807	0.0195	CbGbCtD
Desipramine—CYP2E1—Mitoxantrone—breast cancer	0.00798	0.0192	CbGbCtD
Desipramine—CYP3A4—Anastrozole—breast cancer	0.00742	0.0179	CbGbCtD
Desipramine—CYP3A4—Toremifene—breast cancer	0.00679	0.0164	CbGbCtD
Desipramine—CYP3A4—Fulvestrant—breast cancer	0.00631	0.0152	CbGbCtD
Desipramine—CYP2B6—Irinotecan—breast cancer	0.0062	0.0149	CbGbCtD
Desipramine—CYP3A4—Thiotepa—breast cancer	0.00563	0.0136	CbGbCtD
Desipramine—CYP3A4—Ixabepilone—breast cancer	0.00515	0.0124	CbGbCtD
Desipramine—CYP2C19—Tamoxifen—breast cancer	0.00513	0.0124	CbGbCtD
Desipramine—CYP3A4—Lapatinib—breast cancer	0.00495	0.0119	CbGbCtD
Desipramine—CYP1A2—Tamoxifen—breast cancer	0.00473	0.0114	CbGbCtD
Desipramine—ABCB1—Vinorelbine—breast cancer	0.00459	0.0111	CbGbCtD
Desipramine—CYP2D6—Vinorelbine—breast cancer	0.00432	0.0104	CbGbCtD
Desipramine—ABCB1—Tamoxifen—breast cancer	0.00414	0.00998	CbGbCtD
Desipramine—ABCB1—Mitoxantrone—breast cancer	0.00404	0.00973	CbGbCtD
Desipramine—CYP2D6—Tamoxifen—breast cancer	0.0039	0.0094	CbGbCtD
Desipramine—CYP3A4—Raloxifene—breast cancer	0.00375	0.00905	CbGbCtD
Desipramine—ABCB1—Gemcitabine—breast cancer	0.00357	0.0086	CbGbCtD
Desipramine—CYP1A2—Fluorouracil—breast cancer	0.00349	0.00841	CbGbCtD
Desipramine—CYP2B6—Doxorubicin—breast cancer	0.00339	0.00817	CbGbCtD
Desipramine—ABCB1—Paclitaxel—breast cancer	0.00322	0.00777	CbGbCtD
Desipramine—ABCB1—Irinotecan—breast cancer	0.00318	0.00766	CbGbCtD
Desipramine—ABCB1—Vinblastine—breast cancer	0.00283	0.00681	CbGbCtD
Desipramine—CYP3A4—Vinorelbine—breast cancer	0.00275	0.00662	CbGbCtD
Desipramine—CHRM3—muscle of abdomen—breast cancer	0.00272	0.0891	CbGeAlD
Desipramine—CYP2D6—Vinblastine—breast cancer	0.00266	0.00642	CbGbCtD
Desipramine—CYP3A4—Tamoxifen—breast cancer	0.00248	0.00598	CbGbCtD
Desipramine—CYP3A4—Mitoxantrone—breast cancer	0.00242	0.00583	CbGbCtD
Desipramine—ABCB1—Docetaxel—breast cancer	0.00233	0.00562	CbGbCtD
Desipramine—CYP3A4—Paclitaxel—breast cancer	0.00193	0.00465	CbGbCtD
Desipramine—CYP3A4—Irinotecan—breast cancer	0.0019	0.00459	CbGbCtD
Desipramine—ABCB1—Doxorubicin—breast cancer	0.00174	0.00419	CbGbCtD
Desipramine—CYP3A4—Vinblastine—breast cancer	0.00169	0.00408	CbGbCtD
Desipramine—ABCB1—Methotrexate—breast cancer	0.00168	0.00406	CbGbCtD
Desipramine—CYP2D6—Doxorubicin—breast cancer	0.00164	0.00394	CbGbCtD
Desipramine—CYP3A4—Docetaxel—breast cancer	0.0014	0.00337	CbGbCtD
Desipramine—CYP3A4—Doxorubicin—breast cancer	0.00104	0.00251	CbGbCtD
Desipramine—SMPD1—skin of body—breast cancer	0.000827	0.0271	CbGeAlD
Desipramine—SLC22A4—mammary gland—breast cancer	0.000735	0.0241	CbGeAlD
Desipramine—SMPD1—adipose tissue—breast cancer	0.000702	0.023	CbGeAlD
Desipramine—SMPD1—female reproductive system—breast cancer	0.000646	0.0212	CbGeAlD
Desipramine—SMPD1—adrenal gland—breast cancer	0.00063	0.0207	CbGeAlD
Desipramine—SMPD1—female gonad—breast cancer	0.000587	0.0193	CbGeAlD
Desipramine—CHRM5—epithelium—breast cancer	0.000578	0.019	CbGeAlD
Desipramine—SLC22A3—nipple—breast cancer	0.000553	0.0182	CbGeAlD
Desipramine—CHRM5—skin of body—breast cancer	0.00055	0.018	CbGeAlD
Desipramine—SMPD1—endocrine gland—breast cancer	0.000546	0.0179	CbGeAlD
Desipramine—SLC22A5—mammary gland—breast cancer	0.000486	0.016	CbGeAlD
Desipramine—SLC22A3—embryo—breast cancer	0.000457	0.015	CbGeAlD
Desipramine—CYP2C18—endocrine gland—breast cancer	0.000444	0.0146	CbGeAlD
Desipramine—SLC22A5—nipple—breast cancer	0.000402	0.0132	CbGeAlD
Desipramine—ORM1—endometrium—breast cancer	0.000382	0.0125	CbGeAlD
Desipramine—SMPD1—lymph node—breast cancer	0.000378	0.0124	CbGeAlD
Desipramine—CYP2A6—adipose tissue—breast cancer	0.000378	0.0124	CbGeAlD
Desipramine—SLC22A4—endometrium—breast cancer	0.000367	0.012	CbGeAlD
Desipramine—CYP1A2—nipple—breast cancer	0.000365	0.012	CbGeAlD
Desipramine—Dimetacrine—ACHE—breast cancer	0.000347	0.114	CrCbGaD
Desipramine—HRH1—nipple—breast cancer	0.000341	0.0112	CbGeAlD
Desipramine—SLC22A3—endometrium—breast cancer	0.000334	0.011	CbGeAlD
Desipramine—SLC22A4—pituitary gland—breast cancer	0.000332	0.0109	CbGeAlD
Desipramine—SLC22A4—adipose tissue—breast cancer	0.000331	0.0109	CbGeAlD
Desipramine—ORM1—female reproductive system—breast cancer	0.000316	0.0104	CbGeAlD
Desipramine—SLC22A1—adipose tissue—breast cancer	0.000315	0.0103	CbGeAlD
Desipramine—SLC22A4—female reproductive system—breast cancer	0.000304	0.00998	CbGeAlD
Desipramine—ADRB1—adipose tissue—breast cancer	0.000303	0.00995	CbGeAlD
Desipramine—SLC22A3—adipose tissue—breast cancer	0.000301	0.00988	CbGeAlD
Desipramine—ORM1—bone marrow—breast cancer	0.000298	0.00979	CbGeAlD
Desipramine—SLC22A4—adrenal gland—breast cancer	0.000297	0.00973	CbGeAlD
Desipramine—SLC22A4—bone marrow—breast cancer	0.000287	0.00942	CbGeAlD
Desipramine—HTR2C—female reproductive system—breast cancer	0.000284	0.00932	CbGeAlD
Desipramine—ADRB1—female reproductive system—breast cancer	0.000279	0.00915	CbGeAlD
Desipramine—SLC22A3—female reproductive system—breast cancer	0.000277	0.00908	CbGeAlD
Desipramine—SLC22A3—adrenal gland—breast cancer	0.00027	0.00886	CbGeAlD
Desipramine—SLC6A4—female reproductive system—breast cancer	0.000269	0.00884	CbGeAlD
Desipramine—CHRM1—female reproductive system—breast cancer	0.000268	0.0088	CbGeAlD
Desipramine—ORM1—endocrine gland—breast cancer	0.000268	0.00878	CbGeAlD
Desipramine—CHRM3—adipose tissue—breast cancer	0.000261	0.00857	CbGeAlD
Desipramine—SLC22A5—skin of body—breast cancer	0.000258	0.00845	CbGeAlD
Desipramine—SLC22A3—female gonad—breast cancer	0.000252	0.00826	CbGeAlD
Desipramine—CHRM2—endocrine gland—breast cancer	0.000249	0.00818	CbGeAlD
Desipramine—SLC22A1—endocrine gland—breast cancer	0.000245	0.00804	CbGeAlD
Desipramine—SLC22A5—endometrium—breast cancer	0.000243	0.00797	CbGeAlD
Desipramine—CHRM3—female reproductive system—breast cancer	0.00024	0.00788	CbGeAlD
Desipramine—SLC6A2—female reproductive system—breast cancer	0.000237	0.00778	CbGeAlD
Desipramine—DRD2—pituitary gland—breast cancer	0.000236	0.00774	CbGeAlD
Desipramine—ADRB1—endocrine gland—breast cancer	0.000236	0.00774	CbGeAlD
Desipramine—HTR2A—embryo—breast cancer	0.000235	0.00771	CbGeAlD
Desipramine—SLC22A3—endocrine gland—breast cancer	0.000234	0.00768	CbGeAlD
Desipramine—HTR1A—adrenal gland—breast cancer	0.000233	0.00766	CbGeAlD
Desipramine—SLC6A2—adrenal gland—breast cancer	0.000231	0.00759	CbGeAlD
Desipramine—HRH1—epithelium—breast cancer	0.00023	0.00754	CbGeAlD
Desipramine—SLC6A4—endocrine gland—breast cancer	0.000228	0.00748	CbGeAlD
Desipramine—CHRM1—endocrine gland—breast cancer	0.000227	0.00745	CbGeAlD
Desipramine—CYP2B6—skin of body—breast cancer	0.000224	0.00734	CbGeAlD
Desipramine—SLC22A5—pituitary gland—breast cancer	0.00022	0.00721	CbGeAlD
Desipramine—SLC22A5—adipose tissue—breast cancer	0.000219	0.00718	CbGeAlD
Desipramine—CHRM3—female gonad—breast cancer	0.000219	0.00717	CbGeAlD
Desipramine—HRH1—endometrium—breast cancer	0.000206	0.00676	CbGeAlD
Desipramine—CHRM3—endocrine gland—breast cancer	0.000203	0.00667	CbGeAlD
Desipramine—HTR1A—endocrine gland—breast cancer	0.000202	0.00664	CbGeAlD
Desipramine—SLC22A5—female reproductive system—breast cancer	0.000201	0.0066	CbGeAlD
Desipramine—SLC6A2—endocrine gland—breast cancer	0.000201	0.00658	CbGeAlD
Desipramine—Benazepril—MTHFR—breast cancer	0.000197	0.0646	CrCbGaD
Desipramine—SLC22A5—adrenal gland—breast cancer	0.000196	0.00644	CbGeAlD
Desipramine—HTR2A—epithelium—breast cancer	0.000192	0.00629	CbGeAlD
Desipramine—CYP2C19—endocrine gland—breast cancer	0.000189	0.0062	CbGeAlD
Desipramine—HRH1—adipose tissue—breast cancer	0.000186	0.00609	CbGeAlD
Desipramine—ORM1—lymph node—breast cancer	0.000185	0.00607	CbGeAlD
Desipramine—SLC22A5—female gonad—breast cancer	0.000183	0.00601	CbGeAlD
Desipramine—DRD2—endocrine gland—breast cancer	0.000183	0.006	CbGeAlD
Desipramine—SLC22A4—lymph node—breast cancer	0.000178	0.00584	CbGeAlD
Desipramine—CYP2B6—female reproductive system—breast cancer	0.000175	0.00573	CbGeAlD
Desipramine—HRH1—female reproductive system—breast cancer	0.000171	0.0056	CbGeAlD
Desipramine—CYP2B6—adrenal gland—breast cancer	0.000171	0.00559	CbGeAlD
Desipramine—HRH1—adrenal gland—breast cancer	0.000167	0.00546	CbGeAlD
Desipramine—CYP2E1—female reproductive system—breast cancer	0.000164	0.00538	CbGeAlD
Desipramine—SLC22A3—lymph node—breast cancer	0.000162	0.00531	CbGeAlD
Desipramine—CYP2E1—adrenal gland—breast cancer	0.00016	0.00525	CbGeAlD
Desipramine—HTR2A—pituitary gland—breast cancer	0.000156	0.00511	CbGeAlD
Desipramine—HRH1—female gonad—breast cancer	0.000155	0.00509	CbGeAlD
Desipramine—CYP1A2—endocrine gland—breast cancer	0.000154	0.00506	CbGeAlD
Desipramine—ABCB1—embryo—breast cancer	0.000154	0.00505	CbGeAlD
Desipramine—CYP2B6—endocrine gland—breast cancer	0.000148	0.00485	CbGeAlD
Desipramine—HRH1—endocrine gland—breast cancer	0.000144	0.00474	CbGeAlD
Desipramine—HTR2A—female reproductive system—breast cancer	0.000143	0.00468	CbGeAlD
Desipramine—HTR2A—adrenal gland—breast cancer	0.000139	0.00456	CbGeAlD
Desipramine—CYP2E1—endocrine gland—breast cancer	0.000139	0.00455	CbGeAlD
Desipramine—SLC6A2—lymph node—breast cancer	0.000139	0.00455	CbGeAlD
Desipramine—CYP3A4—female reproductive system—breast cancer	0.000132	0.00433	CbGeAlD
Desipramine—CYP2D6—female reproductive system—breast cancer	0.00013	0.00426	CbGeAlD
Desipramine—ABCB1—epithelium—breast cancer	0.000126	0.00412	CbGeAlD
Desipramine—Ethopropazine—BCHE—breast cancer	0.000121	0.0398	CrCbGaD
Desipramine—HTR2A—endocrine gland—breast cancer	0.000121	0.00396	CbGeAlD
Desipramine—CYP2D6—female gonad—breast cancer	0.000118	0.00388	CbGeAlD
Desipramine—SLC22A5—lymph node—breast cancer	0.000118	0.00386	CbGeAlD
Desipramine—ABCB1—endometrium—breast cancer	0.000113	0.0037	CbGeAlD
Desipramine—CYP3A4—endocrine gland—breast cancer	0.000112	0.00366	CbGeAlD
Desipramine—CYP2D6—endocrine gland—breast cancer	0.00011	0.0036	CbGeAlD
Desipramine—Azatadine—CYP3A4—breast cancer	0.000107	0.0353	CrCbGaD
Desipramine—ABCB1—uterus—breast cancer	0.000104	0.00341	CbGeAlD
Desipramine—ABCB1—pituitary gland—breast cancer	0.000102	0.00335	CbGeAlD
Desipramine—Clomipramine—GSTP1—breast cancer	0.000102	0.0334	CrCbGaD
Desipramine—ABCB1—adipose tissue—breast cancer	0.000102	0.00333	CbGeAlD
Desipramine—HRH1—lymph node—breast cancer	9.98e-05	0.00327	CbGeAlD
Desipramine—Triflupromazine—BCHE—breast cancer	9.93e-05	0.0326	CrCbGaD
Desipramine—Protriptyline—CYP2D6—breast cancer	9.77e-05	0.0321	CrCbGaD
Desipramine—ABCB1—female reproductive system—breast cancer	9.34e-05	0.00306	CbGeAlD
Desipramine—ABCB1—adrenal gland—breast cancer	9.12e-05	0.00299	CbGeAlD
Desipramine—ABCB1—bone marrow—breast cancer	8.82e-05	0.00289	CbGeAlD
Desipramine—Aprindine—CYP2D6—breast cancer	8.58e-05	0.0282	CrCbGaD
Desipramine—ABCB1—female gonad—breast cancer	8.5e-05	0.00279	CbGeAlD
Desipramine—ABCB1—endocrine gland—breast cancer	7.91e-05	0.00259	CbGeAlD
Desipramine—Epinastine—CYP2D6—breast cancer	7.24e-05	0.0238	CrCbGaD
Desipramine—Protriptyline—ABCB1—breast cancer	6.98e-05	0.0229	CrCbGaD
Desipramine—Mequitazine—CYP2D6—breast cancer	6.81e-05	0.0224	CrCbGaD
Desipramine—Alimemazine—CYP3A4—breast cancer	6.79e-05	0.0223	CrCbGaD
Desipramine—Maprotiline—CYP2D6—breast cancer	6.23e-05	0.0205	CrCbGaD
Desipramine—Epinastine—CYP3A4—breast cancer	6.21e-05	0.0204	CrCbGaD
Desipramine—Eosinophilia—Doxorubicin—breast cancer	5.92e-05	0.000457	CcSEcCtD
Desipramine—Palpitations—Docetaxel—breast cancer	5.9e-05	0.000455	CcSEcCtD
Desipramine—Weight increased—Epirubicin—breast cancer	5.88e-05	0.000454	CcSEcCtD
Desipramine—Mequitazine—CYP3A4—breast cancer	5.84e-05	0.0192	CrCbGaD
Desipramine—Malaise—Capecitabine—breast cancer	5.83e-05	0.00045	CcSEcCtD
Desipramine—Insomnia—Paclitaxel—breast cancer	5.82e-05	0.000449	CcSEcCtD
Desipramine—Vomiting—Thiotepa—breast cancer	5.81e-05	0.000448	CcSEcCtD
Desipramine—Convulsion—Docetaxel—breast cancer	5.79e-05	0.000446	CcSEcCtD
Desipramine—Paraesthesia—Paclitaxel—breast cancer	5.78e-05	0.000445	CcSEcCtD
Desipramine—Hypertension—Docetaxel—breast cancer	5.77e-05	0.000445	CcSEcCtD
Desipramine—Drowsiness—Epirubicin—breast cancer	5.77e-05	0.000445	CcSEcCtD
Desipramine—Rash—Thiotepa—breast cancer	5.76e-05	0.000444	CcSEcCtD
Desipramine—Dermatitis—Thiotepa—breast cancer	5.75e-05	0.000444	CcSEcCtD
Desipramine—Agranulocytosis—Methotrexate—breast cancer	5.75e-05	0.000443	CcSEcCtD
Desipramine—Oxcarbazepine—CYP3A4—breast cancer	5.72e-05	0.0188	CrCbGaD
Desipramine—Headache—Thiotepa—breast cancer	5.72e-05	0.000441	CcSEcCtD
Desipramine—Somnolence—Paclitaxel—breast cancer	5.72e-05	0.000441	CcSEcCtD
Desipramine—Palpitations—Capecitabine—breast cancer	5.72e-05	0.000441	CcSEcCtD
Desipramine—Nausea—Vinorelbine—breast cancer	5.68e-05	0.000438	CcSEcCtD
Desipramine—Dyspepsia—Paclitaxel—breast cancer	5.66e-05	0.000437	CcSEcCtD
Desipramine—Asthenia—Mitoxantrone—breast cancer	5.66e-05	0.000436	CcSEcCtD
Desipramine—Asthenia—Irinotecan—breast cancer	5.66e-05	0.000436	CcSEcCtD
Desipramine—Neuropathy peripheral—Epirubicin—breast cancer	5.65e-05	0.000436	CcSEcCtD
Desipramine—Stomatitis—Epirubicin—breast cancer	5.62e-05	0.000433	CcSEcCtD
Desipramine—Jaundice—Epirubicin—breast cancer	5.62e-05	0.000433	CcSEcCtD
Desipramine—Decreased appetite—Paclitaxel—breast cancer	5.59e-05	0.000431	CcSEcCtD
Desipramine—Hypertension—Capecitabine—breast cancer	5.58e-05	0.000431	CcSEcCtD
Desipramine—Dry mouth—Docetaxel—breast cancer	5.56e-05	0.000429	CcSEcCtD
Desipramine—Fatigue—Paclitaxel—breast cancer	5.55e-05	0.000428	CcSEcCtD
Desipramine—Hepatitis—Methotrexate—breast cancer	5.53e-05	0.000427	CcSEcCtD
Desipramine—Pollakiuria—Doxorubicin—breast cancer	5.53e-05	0.000426	CcSEcCtD
Desipramine—Asthenia—Gemcitabine—breast cancer	5.51e-05	0.000425	CcSEcCtD
Desipramine—Nortriptyline—PTGS1—breast cancer	5.5e-05	0.0181	CrCbGaD
Desipramine—Constipation—Paclitaxel—breast cancer	5.5e-05	0.000424	CcSEcCtD
Desipramine—Confusional state—Docetaxel—breast cancer	5.5e-05	0.000424	CcSEcCtD
Desipramine—Anxiety—Capecitabine—breast cancer	5.49e-05	0.000423	CcSEcCtD
Desipramine—ABCB1—lymph node—breast cancer	5.46e-05	0.00179	CbGeAlD
Desipramine—Oedema—Docetaxel—breast cancer	5.45e-05	0.000421	CcSEcCtD
Desipramine—Weight increased—Doxorubicin—breast cancer	5.44e-05	0.00042	CcSEcCtD
Desipramine—Discomfort—Capecitabine—breast cancer	5.44e-05	0.00042	CcSEcCtD
Desipramine—Pruritus—Gemcitabine—breast cancer	5.43e-05	0.000419	CcSEcCtD
Desipramine—Nausea—Thiotepa—breast cancer	5.42e-05	0.000418	CcSEcCtD
Desipramine—Diarrhoea—Mitoxantrone—breast cancer	5.4e-05	0.000416	CcSEcCtD
Desipramine—Diarrhoea—Irinotecan—breast cancer	5.4e-05	0.000416	CcSEcCtD
Desipramine—Dry mouth—Capecitabine—breast cancer	5.38e-05	0.000415	CcSEcCtD
Desipramine—Agranulocytosis—Epirubicin—breast cancer	5.38e-05	0.000415	CcSEcCtD
Desipramine—Pruritus—Fluorouracil—breast cancer	5.34e-05	0.000412	CcSEcCtD
Desipramine—Thrombocytopenia—Docetaxel—breast cancer	5.34e-05	0.000412	CcSEcCtD
Desipramine—Drowsiness—Doxorubicin—breast cancer	5.33e-05	0.000411	CcSEcCtD
Desipramine—Confusional state—Capecitabine—breast cancer	5.32e-05	0.000411	CcSEcCtD
Desipramine—Tachycardia—Docetaxel—breast cancer	5.32e-05	0.00041	CcSEcCtD
Desipramine—Feeling abnormal—Paclitaxel—breast cancer	5.3e-05	0.000409	CcSEcCtD
Desipramine—Oedema—Capecitabine—breast cancer	5.28e-05	0.000407	CcSEcCtD
Desipramine—Diarrhoea—Gemcitabine—breast cancer	5.26e-05	0.000405	CcSEcCtD
Desipramine—Neuropathy peripheral—Doxorubicin—breast cancer	5.23e-05	0.000403	CcSEcCtD
Desipramine—Dizziness—Irinotecan—breast cancer	5.21e-05	0.000402	CcSEcCtD
Desipramine—Jaundice—Doxorubicin—breast cancer	5.2e-05	0.000401	CcSEcCtD
Desipramine—Stomatitis—Doxorubicin—breast cancer	5.2e-05	0.000401	CcSEcCtD
Desipramine—Anorexia—Docetaxel—breast cancer	5.2e-05	0.000401	CcSEcCtD
Desipramine—Hepatitis—Epirubicin—breast cancer	5.18e-05	0.000399	CcSEcCtD
Desipramine—Epinastine—ABCB1—breast cancer	5.17e-05	0.017	CrCbGaD
Desipramine—Diarrhoea—Fluorouracil—breast cancer	5.17e-05	0.000399	CcSEcCtD
Desipramine—Thrombocytopenia—Capecitabine—breast cancer	5.17e-05	0.000399	CcSEcCtD
Desipramine—Tinnitus—Methotrexate—breast cancer	5.16e-05	0.000398	CcSEcCtD
Desipramine—Tachycardia—Capecitabine—breast cancer	5.15e-05	0.000397	CcSEcCtD
Desipramine—Hypoaesthesia—Epirubicin—breast cancer	5.15e-05	0.000397	CcSEcCtD
Desipramine—Urticaria—Paclitaxel—breast cancer	5.11e-05	0.000394	CcSEcCtD
Desipramine—Hypotension—Docetaxel—breast cancer	5.09e-05	0.000393	CcSEcCtD
Desipramine—Abdominal pain—Paclitaxel—breast cancer	5.08e-05	0.000392	CcSEcCtD
Desipramine—Body temperature increased—Paclitaxel—breast cancer	5.08e-05	0.000392	CcSEcCtD
Desipramine—Anorexia—Capecitabine—breast cancer	5.03e-05	0.000388	CcSEcCtD
Desipramine—Vomiting—Irinotecan—breast cancer	5.01e-05	0.000387	CcSEcCtD
Desipramine—Vomiting—Mitoxantrone—breast cancer	5.01e-05	0.000387	CcSEcCtD
Desipramine—Dizziness—Fluorouracil—breast cancer	4.99e-05	0.000385	CcSEcCtD
Desipramine—Oxcarbazepine—ALB—breast cancer	4.99e-05	0.0164	CrCbGaD
Desipramine—Agranulocytosis—Doxorubicin—breast cancer	4.98e-05	0.000384	CcSEcCtD
Desipramine—Rash—Irinotecan—breast cancer	4.97e-05	0.000384	CcSEcCtD
Desipramine—Rash—Mitoxantrone—breast cancer	4.97e-05	0.000384	CcSEcCtD
Desipramine—Dermatitis—Irinotecan—breast cancer	4.97e-05	0.000383	CcSEcCtD
Desipramine—Dermatitis—Mitoxantrone—breast cancer	4.97e-05	0.000383	CcSEcCtD
Desipramine—Headache—Mitoxantrone—breast cancer	4.94e-05	0.000381	CcSEcCtD
Desipramine—Headache—Irinotecan—breast cancer	4.94e-05	0.000381	CcSEcCtD
Desipramine—Hypotension—Capecitabine—breast cancer	4.93e-05	0.00038	CcSEcCtD
Desipramine—Insomnia—Docetaxel—breast cancer	4.93e-05	0.00038	CcSEcCtD
Desipramine—Paraesthesia—Docetaxel—breast cancer	4.9e-05	0.000378	CcSEcCtD
Desipramine—Alopecia—Methotrexate—breast cancer	4.89e-05	0.000377	CcSEcCtD
Desipramine—Vomiting—Gemcitabine—breast cancer	4.88e-05	0.000377	CcSEcCtD
Desipramine—Somnolence—Docetaxel—breast cancer	4.85e-05	0.000374	CcSEcCtD
Desipramine—Rash—Gemcitabine—breast cancer	4.84e-05	0.000374	CcSEcCtD
Desipramine—Dermatitis—Gemcitabine—breast cancer	4.84e-05	0.000373	CcSEcCtD
Desipramine—Tinnitus—Epirubicin—breast cancer	4.83e-05	0.000372	CcSEcCtD
Desipramine—Headache—Gemcitabine—breast cancer	4.81e-05	0.000371	CcSEcCtD
Desipramine—Flushing—Epirubicin—breast cancer	4.8e-05	0.000371	CcSEcCtD
Desipramine—Vomiting—Fluorouracil—breast cancer	4.8e-05	0.00037	CcSEcCtD
Desipramine—Dyspepsia—Docetaxel—breast cancer	4.8e-05	0.00037	CcSEcCtD
Desipramine—Chlorpromazine—BCHE—breast cancer	4.79e-05	0.0157	CrCbGaD
Desipramine—Hepatitis—Doxorubicin—breast cancer	4.79e-05	0.000369	CcSEcCtD
Desipramine—Insomnia—Capecitabine—breast cancer	4.77e-05	0.000368	CcSEcCtD
Desipramine—Hypoaesthesia—Doxorubicin—breast cancer	4.76e-05	0.000368	CcSEcCtD
Desipramine—Rash—Fluorouracil—breast cancer	4.76e-05	0.000367	CcSEcCtD
Desipramine—Dermatitis—Fluorouracil—breast cancer	4.76e-05	0.000367	CcSEcCtD
Desipramine—Paraesthesia—Capecitabine—breast cancer	4.74e-05	0.000366	CcSEcCtD
Desipramine—Decreased appetite—Docetaxel—breast cancer	4.74e-05	0.000366	CcSEcCtD
Desipramine—Headache—Fluorouracil—breast cancer	4.73e-05	0.000365	CcSEcCtD
Desipramine—Dysgeusia—Methotrexate—breast cancer	4.71e-05	0.000364	CcSEcCtD
Desipramine—Fatigue—Docetaxel—breast cancer	4.7e-05	0.000363	CcSEcCtD
Desipramine—Nausea—Mitoxantrone—breast cancer	4.68e-05	0.000361	CcSEcCtD
Desipramine—Nausea—Irinotecan—breast cancer	4.68e-05	0.000361	CcSEcCtD
Desipramine—Constipation—Docetaxel—breast cancer	4.66e-05	0.00036	CcSEcCtD
Desipramine—Dyspepsia—Capecitabine—breast cancer	4.65e-05	0.000358	CcSEcCtD
Desipramine—Prochlorperazine—CYP2D6—breast cancer	4.63e-05	0.0152	CrCbGaD
Desipramine—Arrhythmia—Epirubicin—breast cancer	4.62e-05	0.000357	CcSEcCtD
Desipramine—Asthenia—Paclitaxel—breast cancer	4.61e-05	0.000356	CcSEcCtD
Desipramine—Decreased appetite—Capecitabine—breast cancer	4.59e-05	0.000354	CcSEcCtD
Desipramine—Alopecia—Epirubicin—breast cancer	4.57e-05	0.000353	CcSEcCtD
Desipramine—Nausea—Gemcitabine—breast cancer	4.56e-05	0.000352	CcSEcCtD
Desipramine—Fatigue—Capecitabine—breast cancer	4.55e-05	0.000351	CcSEcCtD
Desipramine—Pruritus—Paclitaxel—breast cancer	4.55e-05	0.000351	CcSEcCtD
Desipramine—Vision blurred—Methotrexate—breast cancer	4.54e-05	0.00035	CcSEcCtD
Desipramine—Constipation—Capecitabine—breast cancer	4.51e-05	0.000348	CcSEcCtD
Desipramine—Feeling abnormal—Docetaxel—breast cancer	4.49e-05	0.000347	CcSEcCtD
Desipramine—Nausea—Fluorouracil—breast cancer	4.49e-05	0.000346	CcSEcCtD
Desipramine—Ill-defined disorder—Methotrexate—breast cancer	4.47e-05	0.000345	CcSEcCtD
Desipramine—Tinnitus—Doxorubicin—breast cancer	4.46e-05	0.000344	CcSEcCtD
Desipramine—Maprotiline—ABCB1—breast cancer	4.45e-05	0.0146	CrCbGaD
Desipramine—Flushing—Doxorubicin—breast cancer	4.44e-05	0.000343	CcSEcCtD
Desipramine—Dysgeusia—Epirubicin—breast cancer	4.41e-05	0.00034	CcSEcCtD
Desipramine—Diarrhoea—Paclitaxel—breast cancer	4.4e-05	0.000339	CcSEcCtD
Desipramine—Feeling abnormal—Capecitabine—breast cancer	4.35e-05	0.000335	CcSEcCtD
Desipramine—Malaise—Methotrexate—breast cancer	4.34e-05	0.000335	CcSEcCtD
Desipramine—Abdominal pain—Docetaxel—breast cancer	4.31e-05	0.000332	CcSEcCtD
Desipramine—Body temperature increased—Docetaxel—breast cancer	4.31e-05	0.000332	CcSEcCtD
Desipramine—Atomoxetine—CYP2D6—breast cancer	4.29e-05	0.0141	CrCbGaD
Desipramine—Arrhythmia—Doxorubicin—breast cancer	4.28e-05	0.00033	CcSEcCtD
Desipramine—Dizziness—Paclitaxel—breast cancer	4.25e-05	0.000328	CcSEcCtD
Desipramine—Vision blurred—Epirubicin—breast cancer	4.25e-05	0.000328	CcSEcCtD
Desipramine—Alopecia—Doxorubicin—breast cancer	4.23e-05	0.000326	CcSEcCtD
Desipramine—Urticaria—Capecitabine—breast cancer	4.19e-05	0.000323	CcSEcCtD
Desipramine—Mianserin—CYP2D6—breast cancer	4.19e-05	0.0138	CrCbGaD
Desipramine—Ill-defined disorder—Epirubicin—breast cancer	4.18e-05	0.000322	CcSEcCtD
Desipramine—Abdominal pain—Capecitabine—breast cancer	4.17e-05	0.000322	CcSEcCtD
Desipramine—Body temperature increased—Capecitabine—breast cancer	4.17e-05	0.000322	CcSEcCtD
Desipramine—Convulsion—Methotrexate—breast cancer	4.17e-05	0.000322	CcSEcCtD
Desipramine—Agitation—Epirubicin—breast cancer	4.14e-05	0.000319	CcSEcCtD
Desipramine—Vomiting—Paclitaxel—breast cancer	4.09e-05	0.000315	CcSEcCtD
Desipramine—Dysgeusia—Doxorubicin—breast cancer	4.08e-05	0.000315	CcSEcCtD
Desipramine—Malaise—Epirubicin—breast cancer	4.06e-05	0.000313	CcSEcCtD
Desipramine—Rash—Paclitaxel—breast cancer	4.06e-05	0.000313	CcSEcCtD
Desipramine—Dermatitis—Paclitaxel—breast cancer	4.05e-05	0.000313	CcSEcCtD
Desipramine—Discomfort—Methotrexate—breast cancer	4.05e-05	0.000312	CcSEcCtD
Desipramine—Headache—Paclitaxel—breast cancer	4.03e-05	0.000311	CcSEcCtD
Desipramine—Palpitations—Epirubicin—breast cancer	3.98e-05	0.000307	CcSEcCtD
Desipramine—Prochlorperazine—CYP3A4—breast cancer	3.97e-05	0.0131	CrCbGaD
Desipramine—Confusional state—Methotrexate—breast cancer	3.96e-05	0.000306	CcSEcCtD
Desipramine—Vision blurred—Doxorubicin—breast cancer	3.93e-05	0.000303	CcSEcCtD
Desipramine—Asthenia—Docetaxel—breast cancer	3.91e-05	0.000302	CcSEcCtD
Desipramine—Convulsion—Epirubicin—breast cancer	3.9e-05	0.000301	CcSEcCtD
Desipramine—Carbamazepine—CYP3A4—breast cancer	3.9e-05	0.0128	CrCbGaD
Desipramine—Triflupromazine—ABCB1—breast cancer	3.89e-05	0.0128	CrCbGaD
Desipramine—Hypertension—Epirubicin—breast cancer	3.89e-05	0.0003	CcSEcCtD
Desipramine—Ill-defined disorder—Doxorubicin—breast cancer	3.87e-05	0.000298	CcSEcCtD
Desipramine—Pruritus—Docetaxel—breast cancer	3.86e-05	0.000298	CcSEcCtD
Desipramine—Thrombocytopenia—Methotrexate—breast cancer	3.85e-05	0.000297	CcSEcCtD
Desipramine—Clomipramine—CYP2D6—breast cancer	3.83e-05	0.0126	CrCbGaD
Desipramine—Agitation—Doxorubicin—breast cancer	3.83e-05	0.000296	CcSEcCtD
Desipramine—Anxiety—Epirubicin—breast cancer	3.82e-05	0.000295	CcSEcCtD
Desipramine—Nausea—Paclitaxel—breast cancer	3.82e-05	0.000295	CcSEcCtD
Desipramine—Discomfort—Epirubicin—breast cancer	3.79e-05	0.000292	CcSEcCtD
Desipramine—Asthenia—Capecitabine—breast cancer	3.79e-05	0.000292	CcSEcCtD
Desipramine—Acepromazine—ALB—breast cancer	3.77e-05	0.0124	CrCbGaD
Desipramine—Malaise—Doxorubicin—breast cancer	3.76e-05	0.00029	CcSEcCtD
Desipramine—Dry mouth—Epirubicin—breast cancer	3.75e-05	0.000289	CcSEcCtD
Desipramine—Anorexia—Methotrexate—breast cancer	3.75e-05	0.000289	CcSEcCtD
Desipramine—Nortriptyline—CYP2D6—breast cancer	3.74e-05	0.0123	CrCbGaD
Desipramine—Pruritus—Capecitabine—breast cancer	3.73e-05	0.000288	CcSEcCtD
Desipramine—Diarrhoea—Docetaxel—breast cancer	3.73e-05	0.000288	CcSEcCtD
Desipramine—Confusional state—Epirubicin—breast cancer	3.71e-05	0.000286	CcSEcCtD
Desipramine—Palpitations—Doxorubicin—breast cancer	3.68e-05	0.000284	CcSEcCtD
Desipramine—Oedema—Epirubicin—breast cancer	3.68e-05	0.000284	CcSEcCtD
Desipramine—Atomoxetine—CYP3A4—breast cancer	3.68e-05	0.0121	CrCbGaD
Desipramine—Hypotension—Methotrexate—breast cancer	3.67e-05	0.000283	CcSEcCtD
Desipramine—Convulsion—Doxorubicin—breast cancer	3.61e-05	0.000279	CcSEcCtD
Desipramine—Diarrhoea—Capecitabine—breast cancer	3.61e-05	0.000279	CcSEcCtD
Desipramine—Dizziness—Docetaxel—breast cancer	3.6e-05	0.000278	CcSEcCtD
Desipramine—Thrombocytopenia—Epirubicin—breast cancer	3.6e-05	0.000278	CcSEcCtD
Desipramine—Hypertension—Doxorubicin—breast cancer	3.6e-05	0.000278	CcSEcCtD
Desipramine—Mianserin—CYP3A4—breast cancer	3.59e-05	0.0118	CrCbGaD
Desipramine—Tachycardia—Epirubicin—breast cancer	3.59e-05	0.000277	CcSEcCtD
Desipramine—Insomnia—Methotrexate—breast cancer	3.55e-05	0.000274	CcSEcCtD
Desipramine—Anxiety—Doxorubicin—breast cancer	3.54e-05	0.000273	CcSEcCtD
Desipramine—Paraesthesia—Methotrexate—breast cancer	3.53e-05	0.000272	CcSEcCtD
Desipramine—Trimipramine—CYP2D6—breast cancer	3.52e-05	0.0116	CrCbGaD
Desipramine—Discomfort—Doxorubicin—breast cancer	3.51e-05	0.00027	CcSEcCtD
Desipramine—Anorexia—Epirubicin—breast cancer	3.5e-05	0.00027	CcSEcCtD
Desipramine—Somnolence—Methotrexate—breast cancer	3.49e-05	0.000269	CcSEcCtD
Desipramine—Dizziness—Capecitabine—breast cancer	3.49e-05	0.000269	CcSEcCtD
Desipramine—Dry mouth—Doxorubicin—breast cancer	3.47e-05	0.000268	CcSEcCtD
Desipramine—Vomiting—Docetaxel—breast cancer	3.47e-05	0.000267	CcSEcCtD
Desipramine—Dyspepsia—Methotrexate—breast cancer	3.46e-05	0.000267	CcSEcCtD
Desipramine—Rash—Docetaxel—breast cancer	3.44e-05	0.000265	CcSEcCtD
Desipramine—Hypotension—Epirubicin—breast cancer	3.44e-05	0.000265	CcSEcCtD
Desipramine—Dermatitis—Docetaxel—breast cancer	3.43e-05	0.000265	CcSEcCtD
Desipramine—Confusional state—Doxorubicin—breast cancer	3.43e-05	0.000265	CcSEcCtD
Desipramine—Decreased appetite—Methotrexate—breast cancer	3.42e-05	0.000263	CcSEcCtD
Desipramine—Headache—Docetaxel—breast cancer	3.42e-05	0.000263	CcSEcCtD
Desipramine—Oedema—Doxorubicin—breast cancer	3.4e-05	0.000262	CcSEcCtD
Desipramine—Promethazine—CYP2D6—breast cancer	3.39e-05	0.0112	CrCbGaD
Desipramine—Fatigue—Methotrexate—breast cancer	3.39e-05	0.000261	CcSEcCtD
Desipramine—Doxepin—CYP2D6—breast cancer	3.36e-05	0.011	CrCbGaD
Desipramine—Vomiting—Capecitabine—breast cancer	3.36e-05	0.000259	CcSEcCtD
Desipramine—Thrombocytopenia—Doxorubicin—breast cancer	3.33e-05	0.000257	CcSEcCtD
Desipramine—Rash—Capecitabine—breast cancer	3.33e-05	0.000257	CcSEcCtD
Desipramine—Insomnia—Epirubicin—breast cancer	3.33e-05	0.000257	CcSEcCtD
Desipramine—Dermatitis—Capecitabine—breast cancer	3.32e-05	0.000256	CcSEcCtD
Desipramine—Tachycardia—Doxorubicin—breast cancer	3.32e-05	0.000256	CcSEcCtD
Desipramine—Headache—Capecitabine—breast cancer	3.31e-05	0.000255	CcSEcCtD
Desipramine—Paraesthesia—Epirubicin—breast cancer	3.3e-05	0.000255	CcSEcCtD
Desipramine—Clomipramine—CYP3A4—breast cancer	3.29e-05	0.0108	CrCbGaD
Desipramine—Somnolence—Epirubicin—breast cancer	3.27e-05	0.000252	CcSEcCtD
Desipramine—Carbamazepine—ABCB1—breast cancer	3.25e-05	0.0107	CrCbGaD
Desipramine—Anorexia—Doxorubicin—breast cancer	3.24e-05	0.00025	CcSEcCtD
Desipramine—Nausea—Docetaxel—breast cancer	3.24e-05	0.00025	CcSEcCtD
Desipramine—Feeling abnormal—Methotrexate—breast cancer	3.24e-05	0.00025	CcSEcCtD
Desipramine—Dyspepsia—Epirubicin—breast cancer	3.24e-05	0.00025	CcSEcCtD
Desipramine—Nortriptyline—CYP3A4—breast cancer	3.21e-05	0.0106	CrCbGaD
Desipramine—Decreased appetite—Epirubicin—breast cancer	3.2e-05	0.000247	CcSEcCtD
Desipramine—Hypotension—Doxorubicin—breast cancer	3.18e-05	0.000245	CcSEcCtD
Desipramine—Fatigue—Epirubicin—breast cancer	3.17e-05	0.000245	CcSEcCtD
Desipramine—Constipation—Epirubicin—breast cancer	3.14e-05	0.000243	CcSEcCtD
Desipramine—Nausea—Capecitabine—breast cancer	3.14e-05	0.000242	CcSEcCtD
Desipramine—Urticaria—Methotrexate—breast cancer	3.12e-05	0.000241	CcSEcCtD
Desipramine—Body temperature increased—Methotrexate—breast cancer	3.11e-05	0.00024	CcSEcCtD
Desipramine—Abdominal pain—Methotrexate—breast cancer	3.11e-05	0.00024	CcSEcCtD
Desipramine—Insomnia—Doxorubicin—breast cancer	3.08e-05	0.000237	CcSEcCtD
Desipramine—Paraesthesia—Doxorubicin—breast cancer	3.06e-05	0.000236	CcSEcCtD
Desipramine—Feeling abnormal—Epirubicin—breast cancer	3.03e-05	0.000234	CcSEcCtD
Desipramine—Somnolence—Doxorubicin—breast cancer	3.02e-05	0.000233	CcSEcCtD
Desipramine—Trimipramine—CYP3A4—breast cancer	3.02e-05	0.00994	CrCbGaD
Desipramine—Dyspepsia—Doxorubicin—breast cancer	2.99e-05	0.000231	CcSEcCtD
Desipramine—Decreased appetite—Doxorubicin—breast cancer	2.96e-05	0.000228	CcSEcCtD
Desipramine—Fatigue—Doxorubicin—breast cancer	2.93e-05	0.000226	CcSEcCtD
Desipramine—Urticaria—Epirubicin—breast cancer	2.92e-05	0.000225	CcSEcCtD
Desipramine—Constipation—Doxorubicin—breast cancer	2.91e-05	0.000224	CcSEcCtD
Desipramine—Body temperature increased—Epirubicin—breast cancer	2.91e-05	0.000224	CcSEcCtD
Desipramine—Abdominal pain—Epirubicin—breast cancer	2.91e-05	0.000224	CcSEcCtD
Desipramine—Doxepin—CYP3A4—breast cancer	2.88e-05	0.00947	CrCbGaD
Desipramine—Clomipramine—ALB—breast cancer	2.87e-05	0.00942	CrCbGaD
Desipramine—Asthenia—Methotrexate—breast cancer	2.82e-05	0.000217	CcSEcCtD
Desipramine—Feeling abnormal—Doxorubicin—breast cancer	2.8e-05	0.000216	CcSEcCtD
Desipramine—Nortriptyline—ALB—breast cancer	2.8e-05	0.00921	CrCbGaD
Desipramine—Pruritus—Methotrexate—breast cancer	2.78e-05	0.000214	CcSEcCtD
Desipramine—Clomipramine—ABCB1—breast cancer	2.74e-05	0.00899	CrCbGaD
Desipramine—Urticaria—Doxorubicin—breast cancer	2.7e-05	0.000208	CcSEcCtD
Desipramine—Abdominal pain—Doxorubicin—breast cancer	2.69e-05	0.000207	CcSEcCtD
Desipramine—Body temperature increased—Doxorubicin—breast cancer	2.69e-05	0.000207	CcSEcCtD
Desipramine—Diarrhoea—Methotrexate—breast cancer	2.69e-05	0.000207	CcSEcCtD
Desipramine—Asthenia—Epirubicin—breast cancer	2.64e-05	0.000203	CcSEcCtD
Desipramine—Chlorpromazine—CYP2D6—breast cancer	2.63e-05	0.00864	CrCbGaD
Desipramine—Imipramine—CYP2D6—breast cancer	2.61e-05	0.00859	CrCbGaD
Desipramine—Pruritus—Epirubicin—breast cancer	2.6e-05	0.000201	CcSEcCtD
Desipramine—Dizziness—Methotrexate—breast cancer	2.6e-05	0.0002	CcSEcCtD
Desipramine—Amitriptyline—CYP2D6—breast cancer	2.6e-05	0.00854	CrCbGaD
Desipramine—Promazine—CYP3A4—breast cancer	2.56e-05	0.00842	CrCbGaD
Desipramine—Trimipramine—ABCB1—breast cancer	2.52e-05	0.00827	CrCbGaD
Desipramine—Diarrhoea—Epirubicin—breast cancer	2.52e-05	0.000194	CcSEcCtD
Desipramine—Vomiting—Methotrexate—breast cancer	2.5e-05	0.000193	CcSEcCtD
Desipramine—Rash—Methotrexate—breast cancer	2.48e-05	0.000191	CcSEcCtD
Desipramine—Dermatitis—Methotrexate—breast cancer	2.48e-05	0.000191	CcSEcCtD
Desipramine—Headache—Methotrexate—breast cancer	2.46e-05	0.00019	CcSEcCtD
Desipramine—Asthenia—Doxorubicin—breast cancer	2.44e-05	0.000188	CcSEcCtD
Desipramine—Dizziness—Epirubicin—breast cancer	2.43e-05	0.000188	CcSEcCtD
Desipramine—Promethazine—ABCB1—breast cancer	2.42e-05	0.00797	CrCbGaD
Desipramine—Pruritus—Doxorubicin—breast cancer	2.41e-05	0.000186	CcSEcCtD
Desipramine—Doxepin—ABCB1—breast cancer	2.4e-05	0.00789	CrCbGaD
Desipramine—Vomiting—Epirubicin—breast cancer	2.34e-05	0.00018	CcSEcCtD
Desipramine—Nausea—Methotrexate—breast cancer	2.33e-05	0.00018	CcSEcCtD
Desipramine—Diarrhoea—Doxorubicin—breast cancer	2.33e-05	0.00018	CcSEcCtD
Desipramine—Rash—Epirubicin—breast cancer	2.32e-05	0.000179	CcSEcCtD
Desipramine—Dermatitis—Epirubicin—breast cancer	2.32e-05	0.000179	CcSEcCtD
Desipramine—Headache—Epirubicin—breast cancer	2.3e-05	0.000178	CcSEcCtD
Desipramine—Chlorpromazine—CYP3A4—breast cancer	2.25e-05	0.00741	CrCbGaD
Desipramine—Dizziness—Doxorubicin—breast cancer	2.25e-05	0.000174	CcSEcCtD
Desipramine—Imipramine—CYP3A4—breast cancer	2.24e-05	0.00737	CrCbGaD
Desipramine—Amitriptyline—CYP3A4—breast cancer	2.23e-05	0.00733	CrCbGaD
Desipramine—Nausea—Epirubicin—breast cancer	2.18e-05	0.000168	CcSEcCtD
Desipramine—Vomiting—Doxorubicin—breast cancer	2.16e-05	0.000167	CcSEcCtD
Desipramine—Rash—Doxorubicin—breast cancer	2.15e-05	0.000165	CcSEcCtD
Desipramine—Dermatitis—Doxorubicin—breast cancer	2.14e-05	0.000165	CcSEcCtD
Desipramine—Headache—Doxorubicin—breast cancer	2.13e-05	0.000164	CcSEcCtD
Desipramine—Nausea—Doxorubicin—breast cancer	2.02e-05	0.000156	CcSEcCtD
Desipramine—Chlorpromazine—ALB—breast cancer	1.97e-05	0.00646	CrCbGaD
Desipramine—Amitriptyline—ALB—breast cancer	1.94e-05	0.00639	CrCbGaD
Desipramine—Chlorpromazine—ABCB1—breast cancer	1.88e-05	0.00617	CrCbGaD
Desipramine—Imipramine—ABCB1—breast cancer	1.87e-05	0.00614	CrCbGaD
Desipramine—Amitriptyline—ABCB1—breast cancer	1.86e-05	0.0061	CrCbGaD
Desipramine—DRD2—Signaling Pathways—CTNNB1—breast cancer	9.18e-07	8.21e-06	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—PIK3CA—breast cancer	9.16e-07	8.2e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—VEGFA—breast cancer	9.16e-07	8.19e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—IL6—breast cancer	9.14e-07	8.18e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CCND1—breast cancer	9.12e-07	8.16e-06	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—STAT3—breast cancer	9.12e-07	8.15e-06	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MAPK3—breast cancer	9.11e-07	8.14e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—JUN—breast cancer	9.1e-07	8.14e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CCND1—breast cancer	9.1e-07	8.14e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—JUN—breast cancer	9.08e-07	8.13e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—COMT—breast cancer	9.08e-07	8.12e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CCND1—breast cancer	9.07e-07	8.12e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—STAT3—breast cancer	9.07e-07	8.11e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—JUN—breast cancer	9.06e-07	8.1e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CCND1—breast cancer	9.05e-07	8.09e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CTNNB1—breast cancer	9.03e-07	8.08e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GSTP1—breast cancer	9.03e-07	8.08e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—JUN—breast cancer	9.03e-07	8.07e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CTNNB1—breast cancer	9.02e-07	8.06e-06	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PIK3CD—breast cancer	9.01e-07	8.06e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MMP9—breast cancer	9e-07	8.05e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CTNNB1—breast cancer	8.99e-07	8.04e-06	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PTEN—breast cancer	8.98e-07	8.03e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CDKN1A—breast cancer	8.97e-07	8.02e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CCND1—breast cancer	8.96e-07	8.01e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CTNNB1—breast cancer	8.96e-07	8.01e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—PTEN—breast cancer	8.95e-07	8e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—JUN—breast cancer	8.94e-07	8e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—HMOX1—breast cancer	8.91e-07	7.97e-06	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MAPK3—breast cancer	8.91e-07	7.97e-06	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—ALB—breast cancer	8.9e-07	7.96e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ITPR1—breast cancer	8.89e-07	7.95e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CTNNB1—breast cancer	8.87e-07	7.93e-06	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—TP53—breast cancer	8.86e-07	7.93e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MMP9—breast cancer	8.86e-07	7.92e-06	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MYC—breast cancer	8.86e-07	7.92e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MMP9—breast cancer	8.84e-07	7.91e-06	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TGFB1—breast cancer	8.83e-07	7.9e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CDKN1A—breast cancer	8.83e-07	7.89e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MMP9—breast cancer	8.81e-07	7.88e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CDKN1A—breast cancer	8.81e-07	7.88e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—PTEN—breast cancer	8.81e-07	7.88e-06	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PTEN—breast cancer	8.8e-07	7.87e-06	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3CD—breast cancer	8.8e-07	7.87e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—PTEN—breast cancer	8.79e-07	7.86e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MMP9—breast cancer	8.78e-07	7.86e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CDKN1A—breast cancer	8.78e-07	7.85e-06	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—PIK3CA—breast cancer	8.78e-07	7.85e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—CAV1—breast cancer	8.77e-07	7.84e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—PTEN—breast cancer	8.76e-07	7.83e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MAPK8—breast cancer	8.75e-07	7.83e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CDKN1A—breast cancer	8.75e-07	7.83e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—AKT1—breast cancer	8.73e-07	7.81e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—PTEN—breast cancer	8.73e-07	7.81e-06	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MAPK3—breast cancer	8.71e-07	7.79e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MMP9—breast cancer	8.7e-07	7.78e-06	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—ALB—breast cancer	8.68e-07	7.77e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CDKN1A—breast cancer	8.67e-07	7.75e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MAPK3—breast cancer	8.66e-07	7.75e-06	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MYC—breast cancer	8.66e-07	7.75e-06	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—EGFR—breast cancer	8.66e-07	7.75e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—PTEN—breast cancer	8.65e-07	7.73e-06	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TGFB1—breast cancer	8.64e-07	7.73e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MAPK8—breast cancer	8.61e-07	7.71e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MAPK8—breast cancer	8.6e-07	7.69e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—AKT1—breast cancer	8.59e-07	7.68e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—AKT1—breast cancer	8.57e-07	7.67e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MAPK8—breast cancer	8.57e-07	7.66e-06	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—PIK3CA—breast cancer	8.56e-07	7.65e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ABCB1—breast cancer	8.55e-07	7.65e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—AKT1—breast cancer	8.54e-07	7.64e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MAPK8—breast cancer	8.54e-07	7.64e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—AKT1—breast cancer	8.52e-07	7.62e-06	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—NOS3—breast cancer	8.51e-07	7.61e-06	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—TP53—breast cancer	8.49e-07	7.59e-06	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—HRAS—breast cancer	8.48e-07	7.58e-06	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—EGFR—breast cancer	8.47e-07	7.58e-06	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MYC—breast cancer	8.47e-07	7.58e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MAPK8—breast cancer	8.46e-07	7.57e-06	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TGFB1—breast cancer	8.45e-07	7.56e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—AKT1—breast cancer	8.43e-07	7.54e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MYC—breast cancer	8.43e-07	7.54e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TGFB1—breast cancer	8.41e-07	7.52e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—TYMS—breast cancer	8.4e-07	7.51e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	8.38e-07	7.49e-06	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—NOS3—breast cancer	8.31e-07	7.43e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PLA2G4A—breast cancer	8.3e-07	7.43e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—NCOR1—breast cancer	8.3e-07	7.43e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GSTM1—breast cancer	8.3e-07	7.43e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—SRC—breast cancer	8.3e-07	7.42e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CD—breast cancer	8.29e-07	7.41e-06	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—EGFR—breast cancer	8.29e-07	7.41e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—EGFR—breast cancer	8.24e-07	7.37e-06	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—KRAS—breast cancer	8.18e-07	7.32e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—ALB—breast cancer	8.18e-07	7.32e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—SRC—breast cancer	8.17e-07	7.3e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—SRC—breast cancer	8.15e-07	7.29e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—SRC—breast cancer	8.12e-07	7.27e-06	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—HRAS—breast cancer	8.12e-07	7.26e-06	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—IL6—breast cancer	8.11e-07	7.26e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—SRC—breast cancer	8.1e-07	7.24e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—VEGFA—breast cancer	8.08e-07	7.23e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—SRC—breast cancer	8.02e-07	7.17e-06	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—KRAS—breast cancer	8e-07	7.16e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—STAT3—breast cancer	8e-07	7.16e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CG—breast cancer	7.99e-07	7.14e-06	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—PIK3CA—breast cancer	7.97e-07	7.13e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—VEGFA—breast cancer	7.95e-07	7.11e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GPX1—breast cancer	7.95e-07	7.11e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—VEGFA—breast cancer	7.94e-07	7.1e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—VEGFA—breast cancer	7.91e-07	7.08e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—VEGFA—breast cancer	7.89e-07	7.05e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—STAT3—breast cancer	7.88e-07	7.04e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CYP1A1—breast cancer	7.87e-07	7.04e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—STAT3—breast cancer	7.86e-07	7.03e-06	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PIK3CB—breast cancer	7.86e-07	7.03e-06	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—PIK3CA—breast cancer	7.85e-07	7.02e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—STAT3—breast cancer	7.83e-07	7.01e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—NOS3—breast cancer	7.83e-07	7e-06	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—KRAS—breast cancer	7.83e-07	7e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—VEGFA—breast cancer	7.81e-07	6.99e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—STAT3—breast cancer	7.81e-07	6.98e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ERCC2—breast cancer	7.81e-07	6.98e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—KRAS—breast cancer	7.79e-07	6.96e-06	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PTGS2—breast cancer	7.78e-07	6.96e-06	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—IL6—breast cancer	7.77e-07	6.95e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—STAT3—breast cancer	7.73e-07	6.92e-06	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3CB—breast cancer	7.67e-07	6.86e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MAPK3—breast cancer	7.65e-07	6.84e-06	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PTGS2—breast cancer	7.6e-07	6.8e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MAPK3—breast cancer	7.52e-07	6.73e-06	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—PIK3CA—breast cancer	7.52e-07	6.72e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MAPK3—breast cancer	7.51e-07	6.72e-06	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—AKT1—breast cancer	7.49e-07	6.7e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MAPK3—breast cancer	7.48e-07	6.69e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MAPK3—breast cancer	7.46e-07	6.67e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MYC—breast cancer	7.44e-07	6.65e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TGFB1—breast cancer	7.42e-07	6.64e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MAPK3—breast cancer	7.39e-07	6.61e-06	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—PIK3CA—breast cancer	7.37e-07	6.59e-06	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—PIK3CA—breast cancer	7.35e-07	6.58e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—MTHFR—breast cancer	7.34e-07	6.56e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MYC—breast cancer	7.32e-07	6.55e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MYC—breast cancer	7.3e-07	6.53e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TGFB1—breast cancer	7.3e-07	6.53e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TGFB1—breast cancer	7.28e-07	6.52e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MYC—breast cancer	7.28e-07	6.51e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—EGFR—breast cancer	7.27e-07	6.51e-06	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TP53—breast cancer	7.27e-07	6.51e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TGFB1—breast cancer	7.26e-07	6.49e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MYC—breast cancer	7.26e-07	6.49e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TGFB1—breast cancer	7.24e-07	6.47e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CB—breast cancer	7.22e-07	6.46e-06	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—PIK3CA—breast cancer	7.19e-07	6.43e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MYC—breast cancer	7.18e-07	6.43e-06	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—AKT1—breast cancer	7.17e-07	6.41e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TGFB1—breast cancer	7.17e-07	6.41e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PTGS2—breast cancer	7.16e-07	6.4e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—EGFR—breast cancer	7.16e-07	6.4e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—PIK3CA—breast cancer	7.15e-07	6.4e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—EGFR—breast cancer	7.14e-07	6.39e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—EGFR—breast cancer	7.12e-07	6.37e-06	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TP53—breast cancer	7.11e-07	6.36e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—EGFR—breast cancer	7.1e-07	6.35e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—EGFR—breast cancer	7.03e-07	6.29e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CD—breast cancer	7.02e-07	6.28e-06	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—AKT1—breast cancer	6.99e-07	6.25e-06	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TP53—breast cancer	6.96e-07	6.22e-06	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—HRAS—breast cancer	6.96e-07	6.22e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—ALB—breast cancer	6.93e-07	6.2e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TP53—breast cancer	6.92e-07	6.19e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—KRAS—breast cancer	6.87e-07	6.15e-06	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—HRAS—breast cancer	6.8e-07	6.09e-06	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PTEN—breast cancer	6.79e-07	6.07e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CAV1—breast cancer	6.77e-07	6.05e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—KRAS—breast cancer	6.76e-07	6.05e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—KRAS—breast cancer	6.75e-07	6.03e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—KRAS—breast cancer	6.73e-07	6.02e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—KRAS—breast cancer	6.7e-07	6e-06	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—IL6—breast cancer	6.66e-07	5.95e-06	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—HRAS—breast cancer	6.65e-07	5.95e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—KRAS—breast cancer	6.64e-07	5.94e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—NOS3—breast cancer	6.63e-07	5.93e-06	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PTEN—breast cancer	6.63e-07	5.93e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—HRAS—breast cancer	6.62e-07	5.92e-06	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—AKT1—breast cancer	6.51e-07	5.83e-06	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—IL6—breast cancer	6.51e-07	5.82e-06	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—AKT1—breast cancer	6.42e-07	5.74e-06	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IL6—breast cancer	6.37e-07	5.7e-06	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PIK3CA—breast cancer	6.34e-07	5.67e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IL6—breast cancer	6.33e-07	5.67e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—PIK3CA—breast cancer	6.31e-07	5.65e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PTEN—breast cancer	6.24e-07	5.58e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—PIK3CA—breast cancer	6.21e-07	5.56e-06	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PIK3CA—breast cancer	6.21e-07	5.55e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—PIK3CA—breast cancer	6.2e-07	5.54e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—PIK3CA—breast cancer	6.18e-07	5.53e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CG—breast cancer	6.16e-07	5.51e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—PIK3CA—breast cancer	6.16e-07	5.51e-06	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—AKT1—breast cancer	6.14e-07	5.49e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CB—breast cancer	6.12e-07	5.47e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TP53—breast cancer	6.11e-07	5.46e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—PIK3CA—breast cancer	6.1e-07	5.46e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PTGS2—breast cancer	6.06e-07	5.42e-06	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—AKT1—breast cancer	6.02e-07	5.38e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TP53—breast cancer	6.01e-07	5.38e-06	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—AKT1—breast cancer	6.01e-07	5.37e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TP53—breast cancer	6e-07	5.36e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TP53—breast cancer	5.98e-07	5.35e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TP53—breast cancer	5.96e-07	5.33e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TP53—breast cancer	5.9e-07	5.28e-06	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—AKT1—breast cancer	5.87e-07	5.25e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—AKT1—breast cancer	5.84e-07	5.23e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—HRAS—breast cancer	5.84e-07	5.22e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—HRAS—breast cancer	5.75e-07	5.14e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—HRAS—breast cancer	5.73e-07	5.13e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—HRAS—breast cancer	5.72e-07	5.11e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—HRAS—breast cancer	5.7e-07	5.1e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—HRAS—breast cancer	5.64e-07	5.05e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IL6—breast cancer	5.59e-07	5e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IL6—breast cancer	5.5e-07	4.92e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IL6—breast cancer	5.49e-07	4.91e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IL6—breast cancer	5.47e-07	4.89e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IL6—breast cancer	5.45e-07	4.88e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CD—breast cancer	5.42e-07	4.85e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IL6—breast cancer	5.4e-07	4.83e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ALB—breast cancer	5.35e-07	4.79e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PTEN—breast cancer	5.29e-07	4.73e-06	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—AKT1—breast cancer	5.18e-07	4.63e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—AKT1—breast cancer	5.16e-07	4.61e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—NOS3—breast cancer	5.12e-07	4.58e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—AKT1—breast cancer	5.07e-07	4.54e-06	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—AKT1—breast cancer	5.07e-07	4.54e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—AKT1—breast cancer	5.06e-07	4.53e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—AKT1—breast cancer	5.05e-07	4.51e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—AKT1—breast cancer	5.03e-07	4.5e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—AKT1—breast cancer	4.98e-07	4.46e-06	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PIK3CA—breast cancer	4.79e-07	4.28e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CB—breast cancer	4.72e-07	4.23e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PTGS2—breast cancer	4.68e-07	4.19e-06	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3CA—breast cancer	4.67e-07	4.18e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CA—breast cancer	4.4e-07	3.94e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PTEN—breast cancer	4.08e-07	3.65e-06	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—AKT1—breast cancer	3.91e-07	3.5e-06	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—AKT1—breast cancer	3.82e-07	3.42e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CA—breast cancer	3.73e-07	3.34e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—AKT1—breast cancer	3.6e-07	3.22e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—AKT1—breast cancer	3.05e-07	2.73e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CA—breast cancer	2.88e-07	2.58e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—AKT1—breast cancer	2.35e-07	2.1e-06	CbGpPWpGaD
